Sandra Ann Carson, MD

Sandra A. Carson, M.D. is Professor and Section Chief of Reproductive Endocrinology and Infertility (REI), Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University Medical School. Prior to Yale, she served as the American College of Obstetricians and Gynecologists’ (ACOG’s) Vice President (VP) of Education. She earned her MD from Northwestern University Medical School, served an OB/GYN residency at Prentice Women’s Hospital, and REI fellowship at University of Chicago/Michael Reese Hospital. Formerly, she was Professor and REI Director at Women and Infants’ Hospital of Rhode Island, Brown University and Tufts Medical School.

As ACOG’s VP of Education she led the team to develop the course for New Department Chairs in OB/GYN, put the annual CREOG resident in-training examination on line, held a summit of OB/GYN leaders to assess resident education, and re-structured the ACOG annual clinical meeting.

Dr Carson also contributed substantially to reproductive medicine and endocrinology. She published over 130 peer-reviewed papers, 60 chapters, and 6 books. She was associate editor for the American Journal of Obstetrics and Gynecology, editor-in-chief of Sexuality, Reproduction and Menopause and Journal Watch, Women’s Health. She was awarded the 2019 Educator of the Year by the American Society of Reproductive Medicine and the 2020 Hero of the Year by the Worldwide EndoMarch

Dr. Carson served as VP of the American Board of Obstetrics and Gynecology (ABOG), and Director of ABOG’s Reproductive Endocrinology and Infertility Division. She was elected VP of ACOG, President of the American Society for Reproductive Medicine and Secretary-Treasurer of the Society of Gynecologic Investigation. She chaired FDA’s Reproductive Drugs Advisory Committee and was consultant to both FDA’s Center for Devices and Radiological Health and the President’s Council on Bioethics. Finally, Dr. Carson’s research was funded by NIH for 18 years. She completed her tenure on NICHD Council. Her latest research development, the Artificial Human Ovary, was named a top 10 medical breakthrough in 2010 by Time magazine and Rhode Island 2011 Innovation of the Year. She holds 14 patents for medical innovations